Kiora Pharmaceuticals Overview
Latest PEG ratio for Kiora Pharmaceuticals: 31.4 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow31.40
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, KPRX shows a PEG ratio of 31.4. That is above the Healthcare sector average of 1.26. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 1.26. Kiora Pharmaceuticals is at 31.4, which is higher that average. That is roughly 2397.6% above the sector mean. Use the comparison chart on this page to see how KPRX stacks up against individual peers as well.
Investors watch KPRX's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Kiora Pharmaceuticals's latest reading is 31.4. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has Kiora Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 31.4) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 1.26, while KPRX is at 31.4. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
